深入药物研发的缝隙2025（英）
Pharma R&D Review 2025 Ian Lloyd, Senior Director, Pharmaprojects Alex Shimmings, Executive Editor, Scrip
报告摘要
Pharma R&D Review 2025 Ian Lloyd, Senior Director, Pharmaprojects Alex Shimmings, Executive Editor, Scrip
报告信息
- 文件全名
- 《深入药物研发的缝隙2025（英）-43页.pdf》
- 适合读者
- 核心数据
- Total Pipeline Size Has Grown by 4.6%
- ▪ 2024 was up 7.2%
- ▪ 38.8% were anticancers
- ▪ 13.8% neurologicals
- 核心议题
常见问题
《深入药物研发的缝隙2025（英）》主要包含哪些内容?
Pharma R&D Review 2025 Ian Lloyd, Senior Director, Pharmaprojects Alex Shimmings, Executive Editor, Scrip核心数据:Total Pipeline Size Has Grown by 4.6%;▪ 2024 was up 7.2%;▪ 38.8% were anticancers。
这份报告覆盖哪一年、篇幅多大?
覆盖 2025 年,全文约 43。
这份报告是免费的吗?如何获取?
本报告免费查阅,登录资料宝后即可在线获取完整内容。
这份报告适合哪些读者?
适合战略规划、行业研究员等读者参考。
报告涉及哪些关键议题?
重点分析了管理咨询等议题。
继续阅读
查看全部 →